nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—hematologic cancer	0.691	1	CbGaD
Tiludronate—PTPN1—hematopoietic system—hematologic cancer	0.00686	0.149	CbGeAlD
Tiludronate—PTPN1—gonad—hematologic cancer	0.00521	0.114	CbGeAlD
Tiludronate—PTPN1—blood—hematologic cancer	0.00454	0.0989	CbGeAlD
Tiludronate—ATP6V1A—hematopoietic system—hematologic cancer	0.00411	0.0894	CbGeAlD
Tiludronate—PTPN1—lung—hematologic cancer	0.00398	0.0867	CbGeAlD
Tiludronate—PTPN1—testis—hematologic cancer	0.00376	0.0818	CbGeAlD
Tiludronate—ATP6V1A—gonad—hematologic cancer	0.00312	0.068	CbGeAlD
Tiludronate—PTPN1—lymph node—hematologic cancer	0.00272	0.0593	CbGeAlD
Tiludronate—ATP6V1A—blood—hematologic cancer	0.00272	0.0592	CbGeAlD
Tiludronate—ATP6V1A—bone marrow—hematologic cancer	0.00263	0.0573	CbGeAlD
Tiludronate—ATP6V1A—lung—hematologic cancer	0.00239	0.0519	CbGeAlD
Tiludronate—ATP6V1A—testis—hematologic cancer	0.00225	0.049	CbGeAlD
Tiludronate—ATP6V1A—lymph node—hematologic cancer	0.00163	0.0355	CbGeAlD
Tiludronate—Headache—Dasatinib—hematologic cancer	0.000164	0.00148	CcSEcCtD
Tiludronate—Headache—Bexarotene—hematologic cancer	0.000164	0.00148	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Thiotepa—hematologic cancer	0.000164	0.00148	CcSEcCtD
Tiludronate—Pain—Bleomycin—hematologic cancer	0.000164	0.00148	CcSEcCtD
Tiludronate—Headache—Fludarabine—hematologic cancer	0.000164	0.00148	CcSEcCtD
Tiludronate—Nausea—Busulfan—hematologic cancer	0.000163	0.00148	CcSEcCtD
Tiludronate—Asthenia—Vinblastine—hematologic cancer	0.000163	0.00147	CcSEcCtD
Tiludronate—Myalgia—Mitoxantrone—hematologic cancer	0.000162	0.00146	CcSEcCtD
Tiludronate—Arthralgia—Mitoxantrone—hematologic cancer	0.000162	0.00146	CcSEcCtD
Tiludronate—Diarrhoea—Cladribine—hematologic cancer	0.000162	0.00146	CcSEcCtD
Tiludronate—Pain—Vinorelbine—hematologic cancer	0.000161	0.00146	CcSEcCtD
Tiludronate—Dizziness—Nilotinib—hematologic cancer	0.00016	0.00145	CcSEcCtD
Tiludronate—Dizziness—Imatinib—hematologic cancer	0.000159	0.00144	CcSEcCtD
Tiludronate—Nausea—Procarbazine—hematologic cancer	0.000159	0.00143	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Thalidomide—hematologic cancer	0.000158	0.00143	CcSEcCtD
Tiludronate—Dyspepsia—Thiotepa—hematologic cancer	0.000158	0.00143	CcSEcCtD
Tiludronate—Myalgia—Gemcitabine—hematologic cancer	0.000158	0.00143	CcSEcCtD
Tiludronate—Arthralgia—Gemcitabine—hematologic cancer	0.000158	0.00143	CcSEcCtD
Tiludronate—Gastrointestinal pain—Bortezomib—hematologic cancer	0.000158	0.00143	CcSEcCtD
Tiludronate—Dizziness—Cladribine—hematologic cancer	0.000156	0.00141	CcSEcCtD
Tiludronate—Nausea—Dasatinib—hematologic cancer	0.000155	0.00141	CcSEcCtD
Tiludronate—Nausea—Bexarotene—hematologic cancer	0.000155	0.00141	CcSEcCtD
Tiludronate—Nausea—Fludarabine—hematologic cancer	0.000155	0.0014	CcSEcCtD
Tiludronate—Diarrhoea—Vinblastine—hematologic cancer	0.000155	0.0014	CcSEcCtD
Tiludronate—Asthenia—Melphalan—hematologic cancer	0.000155	0.0014	CcSEcCtD
Tiludronate—Gastrointestinal pain—Vinorelbine—hematologic cancer	0.000154	0.00139	CcSEcCtD
Tiludronate—Pain—Thiotepa—hematologic cancer	0.000154	0.00139	CcSEcCtD
Tiludronate—Dyspepsia—Thalidomide—hematologic cancer	0.000153	0.00138	CcSEcCtD
Tiludronate—Back pain—Etoposide—hematologic cancer	0.000153	0.00138	CcSEcCtD
Tiludronate—Abdominal pain—Bortezomib—hematologic cancer	0.000152	0.00138	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Carmustine—hematologic cancer	0.000152	0.00138	CcSEcCtD
Tiludronate—Headache—Nilotinib—hematologic cancer	0.000151	0.00137	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Alitretinoin—hematologic cancer	0.000151	0.00136	CcSEcCtD
Tiludronate—Headache—Imatinib—hematologic cancer	0.000151	0.00136	CcSEcCtD
Tiludronate—Asthenia—Lenalidomide—hematologic cancer	0.00015	0.00136	CcSEcCtD
Tiludronate—Dizziness—Vinblastine—hematologic cancer	0.00015	0.00135	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Ifosfamide—hematologic cancer	0.000149	0.00135	CcSEcCtD
Tiludronate—Abdominal pain—Vinorelbine—hematologic cancer	0.000149	0.00135	CcSEcCtD
Tiludronate—Pain—Thalidomide—hematologic cancer	0.000149	0.00134	CcSEcCtD
Tiludronate—Asthenia—Hydroxyurea—hematologic cancer	0.000148	0.00134	CcSEcCtD
Tiludronate—Headache—Cladribine—hematologic cancer	0.000148	0.00134	CcSEcCtD
Tiludronate—Diarrhoea—Melphalan—hematologic cancer	0.000147	0.00133	CcSEcCtD
Tiludronate—Myalgia—Cisplatin—hematologic cancer	0.000147	0.00133	CcSEcCtD
Tiludronate—Gastrointestinal pain—Thiotepa—hematologic cancer	0.000147	0.00133	CcSEcCtD
Tiludronate—Nausea—Chlorambucil—hematologic cancer	0.000147	0.00133	CcSEcCtD
Tiludronate—Dyspepsia—Alitretinoin—hematologic cancer	0.000146	0.00132	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Vincristine—hematologic cancer	0.000145	0.00131	CcSEcCtD
Tiludronate—Nausea—Nilotinib—hematologic cancer	0.000144	0.0013	CcSEcCtD
Tiludronate—Diarrhoea—Lenalidomide—hematologic cancer	0.000143	0.0013	CcSEcCtD
Tiludronate—Pain—Carmustine—hematologic cancer	0.000143	0.00129	CcSEcCtD
Tiludronate—Nausea—Imatinib—hematologic cancer	0.000143	0.00129	CcSEcCtD
Tiludronate—Gastrointestinal pain—Thalidomide—hematologic cancer	0.000142	0.00129	CcSEcCtD
Tiludronate—Vertigo—Etoposide—hematologic cancer	0.000142	0.00129	CcSEcCtD
Tiludronate—Abdominal pain—Thiotepa—hematologic cancer	0.000142	0.00128	CcSEcCtD
Tiludronate—Headache—Vinblastine—hematologic cancer	0.000142	0.00128	CcSEcCtD
Tiludronate—Pain—Alitretinoin—hematologic cancer	0.000142	0.00128	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Mitoxantrone—hematologic cancer	0.000141	0.00128	CcSEcCtD
Tiludronate—Diarrhoea—Hydroxyurea—hematologic cancer	0.000141	0.00128	CcSEcCtD
Tiludronate—Nausea—Cladribine—hematologic cancer	0.00014	0.00127	CcSEcCtD
Tiludronate—Vertigo—Prednisolone—hematologic cancer	0.00014	0.00127	CcSEcCtD
Tiludronate—Pain—Ifosfamide—hematologic cancer	0.00014	0.00126	CcSEcCtD
Tiludronate—Back pain—Triamcinolone—hematologic cancer	0.000139	0.00125	CcSEcCtD
Tiludronate—Dizziness—Lenalidomide—hematologic cancer	0.000139	0.00125	CcSEcCtD
Tiludronate—Asthenia—Bortezomib—hematologic cancer	0.000138	0.00125	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Gemcitabine—hematologic cancer	0.000138	0.00125	CcSEcCtD
Tiludronate—Abdominal pain—Thalidomide—hematologic cancer	0.000137	0.00124	CcSEcCtD
Tiludronate—Asthenia—Bleomycin—hematologic cancer	0.000137	0.00124	CcSEcCtD
Tiludronate—Dyspepsia—Mitoxantrone—hematologic cancer	0.000137	0.00124	CcSEcCtD
Tiludronate—Dyspepsia—Irinotecan—hematologic cancer	0.000137	0.00124	CcSEcCtD
Tiludronate—Dizziness—Hydroxyurea—hematologic cancer	0.000137	0.00123	CcSEcCtD
Tiludronate—Gastrointestinal pain—Carmustine—hematologic cancer	0.000137	0.00123	CcSEcCtD
Tiludronate—Pain—Vincristine—hematologic cancer	0.000136	0.00123	CcSEcCtD
Tiludronate—Gastrointestinal pain—Alitretinoin—hematologic cancer	0.000135	0.00122	CcSEcCtD
Tiludronate—Asthenia—Vinorelbine—hematologic cancer	0.000135	0.00122	CcSEcCtD
Tiludronate—Nausea—Vinblastine—hematologic cancer	0.000135	0.00122	CcSEcCtD
Tiludronate—Gastrointestinal pain—Ifosfamide—hematologic cancer	0.000134	0.00121	CcSEcCtD
Tiludronate—Pain—Irinotecan—hematologic cancer	0.000133	0.0012	CcSEcCtD
Tiludronate—Pain—Mitoxantrone—hematologic cancer	0.000133	0.0012	CcSEcCtD
Tiludronate—Abdominal pain—Carmustine—hematologic cancer	0.000132	0.00119	CcSEcCtD
Tiludronate—Diarrhoea—Bortezomib—hematologic cancer	0.000132	0.00119	CcSEcCtD
Tiludronate—Headache—Lenalidomide—hematologic cancer	0.000131	0.00119	CcSEcCtD
Tiludronate—Abdominal pain—Alitretinoin—hematologic cancer	0.000131	0.00118	CcSEcCtD
Tiludronate—Gastrointestinal pain—Vincristine—hematologic cancer	0.00013	0.00118	CcSEcCtD
Tiludronate—Headache—Hydroxyurea—hematologic cancer	0.000129	0.00117	CcSEcCtD
Tiludronate—Pain—Gemcitabine—hematologic cancer	0.000129	0.00117	CcSEcCtD
Tiludronate—Abdominal pain—Ifosfamide—hematologic cancer	0.000129	0.00117	CcSEcCtD
Tiludronate—Asthenia—Thiotepa—hematologic cancer	0.000129	0.00117	CcSEcCtD
Tiludronate—Vertigo—Triamcinolone—hematologic cancer	0.000129	0.00117	CcSEcCtD
Tiludronate—Diarrhoea—Vinorelbine—hematologic cancer	0.000129	0.00116	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Cisplatin—hematologic cancer	0.000128	0.00116	CcSEcCtD
Tiludronate—Nausea—Melphalan—hematologic cancer	0.000128	0.00116	CcSEcCtD
Tiludronate—Dizziness—Bortezomib—hematologic cancer	0.000128	0.00115	CcSEcCtD
Tiludronate—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000127	0.00115	CcSEcCtD
Tiludronate—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000127	0.00115	CcSEcCtD
Tiludronate—Abdominal pain—Vincristine—hematologic cancer	0.000126	0.00114	CcSEcCtD
Tiludronate—Asthenia—Thalidomide—hematologic cancer	0.000125	0.00113	CcSEcCtD
Tiludronate—Dizziness—Vinorelbine—hematologic cancer	0.000125	0.00113	CcSEcCtD
Tiludronate—Nausea—Lenalidomide—hematologic cancer	0.000124	0.00113	CcSEcCtD
Tiludronate—Diarrhoea—Thiotepa—hematologic cancer	0.000123	0.00111	CcSEcCtD
Tiludronate—Abdominal pain—Mitoxantrone—hematologic cancer	0.000123	0.00111	CcSEcCtD
Tiludronate—Abdominal pain—Irinotecan—hematologic cancer	0.000123	0.00111	CcSEcCtD
Tiludronate—Nausea—Hydroxyurea—hematologic cancer	0.000123	0.00111	CcSEcCtD
Tiludronate—Myalgia—Triamcinolone—hematologic cancer	0.000122	0.0011	CcSEcCtD
Tiludronate—Headache—Bortezomib—hematologic cancer	0.000121	0.00109	CcSEcCtD
Tiludronate—Pain—Cisplatin—hematologic cancer	0.000121	0.00109	CcSEcCtD
Tiludronate—Asthenia—Carmustine—hematologic cancer	0.00012	0.00108	CcSEcCtD
Tiludronate—Diarrhoea—Thalidomide—hematologic cancer	0.000119	0.00108	CcSEcCtD
Tiludronate—Dizziness—Thiotepa—hematologic cancer	0.000119	0.00107	CcSEcCtD
Tiludronate—Asthenia—Alitretinoin—hematologic cancer	0.000119	0.00107	CcSEcCtD
Tiludronate—Headache—Vinorelbine—hematologic cancer	0.000118	0.00107	CcSEcCtD
Tiludronate—Asthenia—Ifosfamide—hematologic cancer	0.000117	0.00106	CcSEcCtD
Tiludronate—Vertigo—Dexamethasone—hematologic cancer	0.000117	0.00106	CcSEcCtD
Tiludronate—Vertigo—Betamethasone—hematologic cancer	0.000117	0.00106	CcSEcCtD
Tiludronate—Dizziness—Thalidomide—hematologic cancer	0.000115	0.00104	CcSEcCtD
Tiludronate—Nausea—Bortezomib—hematologic cancer	0.000115	0.00104	CcSEcCtD
Tiludronate—Asthenia—Vincristine—hematologic cancer	0.000114	0.00103	CcSEcCtD
Tiludronate—Diarrhoea—Carmustine—hematologic cancer	0.000114	0.00103	CcSEcCtD
Tiludronate—Nausea—Bleomycin—hematologic cancer	0.000114	0.00103	CcSEcCtD
Tiludronate—Diarrhoea—Alitretinoin—hematologic cancer	0.000113	0.00102	CcSEcCtD
Tiludronate—Headache—Thiotepa—hematologic cancer	0.000113	0.00102	CcSEcCtD
Tiludronate—Diarrhoea—Ifosfamide—hematologic cancer	0.000112	0.00101	CcSEcCtD
Tiludronate—Nausea—Vinorelbine—hematologic cancer	0.000112	0.00101	CcSEcCtD
Tiludronate—Asthenia—Irinotecan—hematologic cancer	0.000111	0.00101	CcSEcCtD
Tiludronate—Asthenia—Mitoxantrone—hematologic cancer	0.000111	0.00101	CcSEcCtD
Tiludronate—Myalgia—Dexamethasone—hematologic cancer	0.000111	0.001	CcSEcCtD
Tiludronate—Myalgia—Betamethasone—hematologic cancer	0.000111	0.001	CcSEcCtD
Tiludronate—Dizziness—Carmustine—hematologic cancer	0.00011	0.000998	CcSEcCtD
Tiludronate—Pain—Etoposide—hematologic cancer	0.00011	0.000998	CcSEcCtD
Tiludronate—Dizziness—Alitretinoin—hematologic cancer	0.000109	0.000989	CcSEcCtD
Tiludronate—Diarrhoea—Vincristine—hematologic cancer	0.000109	0.000986	CcSEcCtD
Tiludronate—Headache—Thalidomide—hematologic cancer	0.000109	0.000985	CcSEcCtD
Tiludronate—Pain—Prednisolone—hematologic cancer	0.000109	0.000985	CcSEcCtD
Tiludronate—Asthenia—Gemcitabine—hematologic cancer	0.000109	0.000981	CcSEcCtD
Tiludronate—Dizziness—Ifosfamide—hematologic cancer	0.000108	0.000977	CcSEcCtD
Tiludronate—Nausea—Thiotepa—hematologic cancer	0.000107	0.000965	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000107	0.000965	CcSEcCtD
Tiludronate—Diarrhoea—Irinotecan—hematologic cancer	0.000106	0.00096	CcSEcCtD
Tiludronate—Diarrhoea—Mitoxantrone—hematologic cancer	0.000106	0.00096	CcSEcCtD
Tiludronate—Gastrointestinal pain—Etoposide—hematologic cancer	0.000106	0.000955	CcSEcCtD
Tiludronate—Dizziness—Vincristine—hematologic cancer	0.000105	0.000953	CcSEcCtD
Tiludronate—Headache—Carmustine—hematologic cancer	0.000105	0.000946	CcSEcCtD
Tiludronate—Headache—Alitretinoin—hematologic cancer	0.000104	0.000937	CcSEcCtD
Tiludronate—Diarrhoea—Gemcitabine—hematologic cancer	0.000103	0.000935	CcSEcCtD
Tiludronate—Nausea—Thalidomide—hematologic cancer	0.000103	0.000934	CcSEcCtD
Tiludronate—Dyspepsia—Triamcinolone—hematologic cancer	0.000103	0.000932	CcSEcCtD
Tiludronate—Dizziness—Irinotecan—hematologic cancer	0.000103	0.000928	CcSEcCtD
Tiludronate—Rhinitis—Epirubicin—hematologic cancer	0.000102	0.000923	CcSEcCtD
Tiludronate—Abdominal pain—Etoposide—hematologic cancer	0.000102	0.000923	CcSEcCtD
Tiludronate—Vertigo—Prednisone—hematologic cancer	0.000102	0.000921	CcSEcCtD
Tiludronate—Asthenia—Cisplatin—hematologic cancer	0.000101	0.000914	CcSEcCtD
Tiludronate—Pain—Triamcinolone—hematologic cancer	0.0001	0.000905	CcSEcCtD
Tiludronate—Headache—Vincristine—hematologic cancer	9.99e-05	0.000903	CcSEcCtD
Tiludronate—Nausea—Carmustine—hematologic cancer	9.92e-05	0.000897	CcSEcCtD
Tiludronate—Nausea—Alitretinoin—hematologic cancer	9.83e-05	0.000888	CcSEcCtD
Tiludronate—Headache—Irinotecan—hematologic cancer	9.73e-05	0.000879	CcSEcCtD
Tiludronate—Headache—Mitoxantrone—hematologic cancer	9.73e-05	0.000879	CcSEcCtD
Tiludronate—Nausea—Ifosfamide—hematologic cancer	9.71e-05	0.000878	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	9.69e-05	0.000875	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Betamethasone—hematologic cancer	9.69e-05	0.000875	CcSEcCtD
Tiludronate—Myalgia—Prednisone—hematologic cancer	9.66e-05	0.000873	CcSEcCtD
Tiludronate—Arthralgia—Prednisone—hematologic cancer	9.66e-05	0.000873	CcSEcCtD
Tiludronate—Diarrhoea—Cisplatin—hematologic cancer	9.65e-05	0.000872	CcSEcCtD
Tiludronate—Headache—Gemcitabine—hematologic cancer	9.48e-05	0.000856	CcSEcCtD
Tiludronate—Nausea—Vincristine—hematologic cancer	9.47e-05	0.000856	CcSEcCtD
Tiludronate—Rhinitis—Doxorubicin—hematologic cancer	9.45e-05	0.000854	CcSEcCtD
Tiludronate—Dyspepsia—Dexamethasone—hematologic cancer	9.36e-05	0.000846	CcSEcCtD
Tiludronate—Dyspepsia—Betamethasone—hematologic cancer	9.36e-05	0.000846	CcSEcCtD
Tiludronate—Asthenia—Etoposide—hematologic cancer	9.27e-05	0.000838	CcSEcCtD
Tiludronate—Nausea—Mitoxantrone—hematologic cancer	9.22e-05	0.000834	CcSEcCtD
Tiludronate—Nausea—Irinotecan—hematologic cancer	9.22e-05	0.000834	CcSEcCtD
Tiludronate—Back pain—Methotrexate—hematologic cancer	9.17e-05	0.000829	CcSEcCtD
Tiludronate—Pain—Betamethasone—hematologic cancer	9.09e-05	0.000822	CcSEcCtD
Tiludronate—Pain—Dexamethasone—hematologic cancer	9.09e-05	0.000822	CcSEcCtD
Tiludronate—Nausea—Gemcitabine—hematologic cancer	8.99e-05	0.000812	CcSEcCtD
Tiludronate—Diarrhoea—Etoposide—hematologic cancer	8.84e-05	0.000799	CcSEcCtD
Tiludronate—Gastrointestinal pain—Betamethasone—hematologic cancer	8.69e-05	0.000786	CcSEcCtD
Tiludronate—Gastrointestinal pain—Dexamethasone—hematologic cancer	8.69e-05	0.000786	CcSEcCtD
Tiludronate—Back pain—Epirubicin—hematologic cancer	8.58e-05	0.000776	CcSEcCtD
Tiludronate—Dizziness—Etoposide—hematologic cancer	8.54e-05	0.000772	CcSEcCtD
Tiludronate—Vertigo—Methotrexate—hematologic cancer	8.52e-05	0.00077	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.43e-05	0.000762	CcSEcCtD
Tiludronate—Dizziness—Prednisolone—hematologic cancer	8.42e-05	0.000761	CcSEcCtD
Tiludronate—Asthenia—Triamcinolone—hematologic cancer	8.41e-05	0.00076	CcSEcCtD
Tiludronate—Abdominal pain—Betamethasone—hematologic cancer	8.4e-05	0.00076	CcSEcCtD
Tiludronate—Abdominal pain—Dexamethasone—hematologic cancer	8.4e-05	0.00076	CcSEcCtD
Tiludronate—Nausea—Cisplatin—hematologic cancer	8.37e-05	0.000757	CcSEcCtD
Tiludronate—Dyspepsia—Prednisone—hematologic cancer	8.15e-05	0.000737	CcSEcCtD
Tiludronate—Headache—Etoposide—hematologic cancer	8.09e-05	0.000731	CcSEcCtD
Tiludronate—Myalgia—Methotrexate—hematologic cancer	8.07e-05	0.000729	CcSEcCtD
Tiludronate—Arthralgia—Methotrexate—hematologic cancer	8.07e-05	0.000729	CcSEcCtD
Tiludronate—Headache—Prednisolone—hematologic cancer	7.98e-05	0.000721	CcSEcCtD
Tiludronate—Vertigo—Epirubicin—hematologic cancer	7.97e-05	0.00072	CcSEcCtD
Tiludronate—Back pain—Doxorubicin—hematologic cancer	7.94e-05	0.000718	CcSEcCtD
Tiludronate—Dizziness—Triamcinolone—hematologic cancer	7.75e-05	0.0007	CcSEcCtD
Tiludronate—Nausea—Etoposide—hematologic cancer	7.67e-05	0.000693	CcSEcCtD
Tiludronate—Asthenia—Betamethasone—hematologic cancer	7.63e-05	0.000689	CcSEcCtD
Tiludronate—Asthenia—Dexamethasone—hematologic cancer	7.63e-05	0.000689	CcSEcCtD
Tiludronate—Gastrointestinal pain—Prednisone—hematologic cancer	7.57e-05	0.000684	CcSEcCtD
Tiludronate—Nausea—Prednisolone—hematologic cancer	7.57e-05	0.000684	CcSEcCtD
Tiludronate—Myalgia—Epirubicin—hematologic cancer	7.55e-05	0.000683	CcSEcCtD
Tiludronate—Arthralgia—Epirubicin—hematologic cancer	7.55e-05	0.000683	CcSEcCtD
Tiludronate—Vertigo—Doxorubicin—hematologic cancer	7.38e-05	0.000667	CcSEcCtD
Tiludronate—Headache—Triamcinolone—hematologic cancer	7.34e-05	0.000663	CcSEcCtD
Tiludronate—Abdominal pain—Prednisone—hematologic cancer	7.32e-05	0.000661	CcSEcCtD
Tiludronate—Diarrhoea—Dexamethasone—hematologic cancer	7.27e-05	0.000657	CcSEcCtD
Tiludronate—Diarrhoea—Betamethasone—hematologic cancer	7.27e-05	0.000657	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	7.05e-05	0.000637	CcSEcCtD
Tiludronate—Dizziness—Dexamethasone—hematologic cancer	7.03e-05	0.000635	CcSEcCtD
Tiludronate—Dizziness—Betamethasone—hematologic cancer	7.03e-05	0.000635	CcSEcCtD
Tiludronate—Myalgia—Doxorubicin—hematologic cancer	6.99e-05	0.000632	CcSEcCtD
Tiludronate—Arthralgia—Doxorubicin—hematologic cancer	6.99e-05	0.000632	CcSEcCtD
Tiludronate—Nausea—Triamcinolone—hematologic cancer	6.96e-05	0.000629	CcSEcCtD
Tiludronate—Dyspepsia—Methotrexate—hematologic cancer	6.81e-05	0.000616	CcSEcCtD
Tiludronate—Headache—Dexamethasone—hematologic cancer	6.66e-05	0.000602	CcSEcCtD
Tiludronate—Headache—Betamethasone—hematologic cancer	6.66e-05	0.000602	CcSEcCtD
Tiludronate—Asthenia—Prednisone—hematologic cancer	6.64e-05	0.0006	CcSEcCtD
Tiludronate—Pain—Methotrexate—hematologic cancer	6.62e-05	0.000598	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.6e-05	0.000596	CcSEcCtD
Tiludronate—Dyspepsia—Epirubicin—hematologic cancer	6.37e-05	0.000576	CcSEcCtD
Tiludronate—Diarrhoea—Prednisone—hematologic cancer	6.33e-05	0.000572	CcSEcCtD
Tiludronate—Gastrointestinal pain—Methotrexate—hematologic cancer	6.33e-05	0.000572	CcSEcCtD
Tiludronate—Nausea—Dexamethasone—hematologic cancer	6.31e-05	0.000571	CcSEcCtD
Tiludronate—Nausea—Betamethasone—hematologic cancer	6.31e-05	0.000571	CcSEcCtD
Tiludronate—Pain—Epirubicin—hematologic cancer	6.19e-05	0.00056	CcSEcCtD
Tiludronate—Dizziness—Prednisone—hematologic cancer	6.12e-05	0.000553	CcSEcCtD
Tiludronate—Abdominal pain—Methotrexate—hematologic cancer	6.12e-05	0.000553	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.1e-05	0.000552	CcSEcCtD
Tiludronate—Gastrointestinal pain—Epirubicin—hematologic cancer	5.92e-05	0.000535	CcSEcCtD
Tiludronate—Dyspepsia—Doxorubicin—hematologic cancer	5.9e-05	0.000533	CcSEcCtD
Tiludronate—Headache—Prednisone—hematologic cancer	5.8e-05	0.000524	CcSEcCtD
Tiludronate—Pain—Doxorubicin—hematologic cancer	5.73e-05	0.000518	CcSEcCtD
Tiludronate—Abdominal pain—Epirubicin—hematologic cancer	5.72e-05	0.000517	CcSEcCtD
Tiludronate—Asthenia—Methotrexate—hematologic cancer	5.55e-05	0.000502	CcSEcCtD
Tiludronate—Nausea—Prednisone—hematologic cancer	5.5e-05	0.000497	CcSEcCtD
Tiludronate—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.48e-05	0.000495	CcSEcCtD
Tiludronate—Abdominal pain—Doxorubicin—hematologic cancer	5.3e-05	0.000479	CcSEcCtD
Tiludronate—Diarrhoea—Methotrexate—hematologic cancer	5.29e-05	0.000478	CcSEcCtD
Tiludronate—Asthenia—Epirubicin—hematologic cancer	5.19e-05	0.00047	CcSEcCtD
Tiludronate—Dizziness—Methotrexate—hematologic cancer	5.12e-05	0.000462	CcSEcCtD
Tiludronate—Diarrhoea—Epirubicin—hematologic cancer	4.95e-05	0.000448	CcSEcCtD
Tiludronate—Headache—Methotrexate—hematologic cancer	4.85e-05	0.000438	CcSEcCtD
Tiludronate—Asthenia—Doxorubicin—hematologic cancer	4.81e-05	0.000434	CcSEcCtD
Tiludronate—Dizziness—Epirubicin—hematologic cancer	4.79e-05	0.000433	CcSEcCtD
Tiludronate—Nausea—Methotrexate—hematologic cancer	4.6e-05	0.000415	CcSEcCtD
Tiludronate—Diarrhoea—Doxorubicin—hematologic cancer	4.58e-05	0.000414	CcSEcCtD
Tiludronate—Headache—Epirubicin—hematologic cancer	4.54e-05	0.00041	CcSEcCtD
Tiludronate—Dizziness—Doxorubicin—hematologic cancer	4.43e-05	0.0004	CcSEcCtD
Tiludronate—Nausea—Epirubicin—hematologic cancer	4.3e-05	0.000389	CcSEcCtD
Tiludronate—Headache—Doxorubicin—hematologic cancer	4.2e-05	0.000379	CcSEcCtD
Tiludronate—Nausea—Doxorubicin—hematologic cancer	3.98e-05	0.00036	CcSEcCtD
Tiludronate—PTPN1—Immune System—IL2RA—hematologic cancer	2.84e-05	0.000186	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PARP1—hematologic cancer	2.81e-05	0.000184	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PARP1—hematologic cancer	2.81e-05	0.000184	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PDGFRA—hematologic cancer	2.81e-05	0.000184	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HLA-A—hematologic cancer	2.8e-05	0.000184	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—JAK1—hematologic cancer	2.8e-05	0.000184	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PRKCG—hematologic cancer	2.8e-05	0.000184	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FBXW7—hematologic cancer	2.77e-05	0.000181	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FBXW7—hematologic cancer	2.77e-05	0.000181	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SRC—hematologic cancer	2.77e-05	0.000181	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PDGFB—hematologic cancer	2.74e-05	0.000179	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HDAC2—hematologic cancer	2.71e-05	0.000178	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCR4—hematologic cancer	2.71e-05	0.000178	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCR4—hematologic cancer	2.71e-05	0.000178	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HDAC2—hematologic cancer	2.71e-05	0.000178	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—hematologic cancer	2.69e-05	0.000177	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2L1—hematologic cancer	2.69e-05	0.000176	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—TSC2—hematologic cancer	2.68e-05	0.000175	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CRP—hematologic cancer	2.68e-05	0.000175	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—NRAS—hematologic cancer	2.66e-05	0.000174	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CBL—hematologic cancer	2.65e-05	0.000173	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CBL—hematologic cancer	2.65e-05	0.000173	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL3—hematologic cancer	2.62e-05	0.000172	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL3—hematologic cancer	2.62e-05	0.000172	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTHFR—hematologic cancer	2.6e-05	0.00017	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TERT—hematologic cancer	2.59e-05	0.00017	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HLA-A—hematologic cancer	2.59e-05	0.00017	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FGFR3—hematologic cancer	2.57e-05	0.000169	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTPN1—hematologic cancer	2.57e-05	0.000169	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MAPK3—hematologic cancer	2.55e-05	0.000167	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK14—hematologic cancer	2.55e-05	0.000167	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RASGRP1—hematologic cancer	2.53e-05	0.000166	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RASGRP1—hematologic cancer	2.53e-05	0.000166	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PDGFB—hematologic cancer	2.53e-05	0.000166	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HSP90AA1—hematologic cancer	2.52e-05	0.000165	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SYK—hematologic cancer	2.52e-05	0.000165	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HSP90AA1—hematologic cancer	2.52e-05	0.000165	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SYK—hematologic cancer	2.52e-05	0.000165	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TGFB1—hematologic cancer	2.47e-05	0.000162	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TSC2—hematologic cancer	2.47e-05	0.000162	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ICAM1—hematologic cancer	2.46e-05	0.000161	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NFKBIA—hematologic cancer	2.44e-05	0.00016	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BAD—hematologic cancer	2.44e-05	0.00016	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT1—hematologic cancer	2.43e-05	0.000159	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT1—hematologic cancer	2.43e-05	0.000159	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGFR3—hematologic cancer	2.38e-05	0.000156	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD80—hematologic cancer	2.37e-05	0.000155	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KIT—hematologic cancer	2.36e-05	0.000155	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PTPN11—hematologic cancer	2.32e-05	0.000152	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—KRAS—hematologic cancer	2.29e-05	0.00015	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GRB2—hematologic cancer	2.28e-05	0.000149	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GRB2—hematologic cancer	2.28e-05	0.000149	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PDGFA—hematologic cancer	2.27e-05	0.000149	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PDGFA—hematologic cancer	2.27e-05	0.000149	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FOS—hematologic cancer	2.25e-05	0.000148	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—BAD—hematologic cancer	2.25e-05	0.000148	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CREB1—hematologic cancer	2.25e-05	0.000147	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KITLG—hematologic cancer	2.24e-05	0.000147	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KITLG—hematologic cancer	2.24e-05	0.000147	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOTCH1—hematologic cancer	2.23e-05	0.000146	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CASP8—hematologic cancer	2.2e-05	0.000144	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6R—hematologic cancer	2.19e-05	0.000144	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CREBBP—hematologic cancer	2.19e-05	0.000144	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT5A—hematologic cancer	2.19e-05	0.000143	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT5A—hematologic cancer	2.19e-05	0.000143	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CD80—hematologic cancer	2.19e-05	0.000143	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KIT—hematologic cancer	2.18e-05	0.000143	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN2B—hematologic cancer	2.17e-05	0.000142	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN2B—hematologic cancer	2.17e-05	0.000142	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTPN11—hematologic cancer	2.14e-05	0.00014	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CA—hematologic cancer	2.1e-05	0.000138	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CD86—hematologic cancer	2.1e-05	0.000137	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CD86—hematologic cancer	2.1e-05	0.000137	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAP2K1—hematologic cancer	2.09e-05	0.000137	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CD—hematologic cancer	2.08e-05	0.000136	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CREB1—hematologic cancer	2.08e-05	0.000136	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HES1—hematologic cancer	2.07e-05	0.000136	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HES1—hematologic cancer	2.07e-05	0.000136	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NCOR1—hematologic cancer	2.06e-05	0.000135	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NCOR1—hematologic cancer	2.06e-05	0.000135	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—BRAF—hematologic cancer	2.05e-05	0.000134	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—hematologic cancer	2.04e-05	0.000133	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CSF2—hematologic cancer	2.03e-05	0.000133	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGF1—hematologic cancer	2.03e-05	0.000133	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CSF2—hematologic cancer	2.03e-05	0.000133	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGF1—hematologic cancer	2.03e-05	0.000133	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6R—hematologic cancer	2.03e-05	0.000133	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CREBBP—hematologic cancer	2.02e-05	0.000133	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FOXO1—hematologic cancer	2e-05	0.000131	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FOXO1—hematologic cancer	2e-05	0.000131	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PDGFRB—hematologic cancer	2e-05	0.000131	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PDGFRB—hematologic cancer	2e-05	0.000131	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FGF2—hematologic cancer	1.99e-05	0.00013	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PDGFRA—hematologic cancer	1.97e-05	0.000129	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PDGFRA—hematologic cancer	1.97e-05	0.000129	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—JAK1—hematologic cancer	1.96e-05	0.000129	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKCG—hematologic cancer	1.96e-05	0.000129	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKCG—hematologic cancer	1.96e-05	0.000129	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JAK1—hematologic cancer	1.96e-05	0.000129	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3R1—hematologic cancer	1.96e-05	0.000129	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—HRAS—hematologic cancer	1.95e-05	0.000128	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MAP2K1—hematologic cancer	1.93e-05	0.000127	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CD—hematologic cancer	1.92e-05	0.000126	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—JAK2—hematologic cancer	1.91e-05	0.000125	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2—hematologic cancer	1.89e-05	0.000124	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IFNG—hematologic cancer	1.87e-05	0.000123	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MDM2—hematologic cancer	1.86e-05	0.000122	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGF2—hematologic cancer	1.84e-05	0.00012	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL2RA—hematologic cancer	1.83e-05	0.00012	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL2RA—hematologic cancer	1.83e-05	0.00012	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TERT—hematologic cancer	1.81e-05	0.000119	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TERT—hematologic cancer	1.81e-05	0.000119	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3R1—hematologic cancer	1.81e-05	0.000119	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MTOR—hematologic cancer	1.81e-05	0.000119	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CB—hematologic cancer	1.81e-05	0.000119	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD4—hematologic cancer	1.81e-05	0.000118	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PDGFB—hematologic cancer	1.77e-05	0.000116	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PDGFB—hematologic cancer	1.77e-05	0.000116	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—JAK2—hematologic cancer	1.76e-05	0.000115	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TSC2—hematologic cancer	1.73e-05	0.000113	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TSC2—hematologic cancer	1.73e-05	0.000113	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—AKT1—hematologic cancer	1.72e-05	0.000113	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MDM2—hematologic cancer	1.72e-05	0.000113	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1B—hematologic cancer	1.7e-05	0.000111	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CB—hematologic cancer	1.67e-05	0.00011	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTOR—hematologic cancer	1.67e-05	0.00011	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL1B—hematologic cancer	1.67e-05	0.000109	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CD4—hematologic cancer	1.67e-05	0.000109	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGFR3—hematologic cancer	1.66e-05	0.000109	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGFR3—hematologic cancer	1.66e-05	0.000109	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL2—hematologic cancer	1.66e-05	0.000109	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK14—hematologic cancer	1.65e-05	0.000108	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK14—hematologic cancer	1.65e-05	0.000108	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—JUN—hematologic cancer	1.62e-05	0.000106	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ESR1—hematologic cancer	1.62e-05	0.000106	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ESR1—hematologic cancer	1.62e-05	0.000106	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FN1—hematologic cancer	1.6e-05	0.000105	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FN1—hematologic cancer	1.6e-05	0.000105	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NFKBIA—hematologic cancer	1.58e-05	0.000103	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BAD—hematologic cancer	1.58e-05	0.000103	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BAD—hematologic cancer	1.58e-05	0.000103	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NFKBIA—hematologic cancer	1.58e-05	0.000103	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1B—hematologic cancer	1.57e-05	0.000103	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1A—hematologic cancer	1.57e-05	0.000103	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PTEN—hematologic cancer	1.56e-05	0.000103	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOTCH1—hematologic cancer	1.56e-05	0.000102	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOTCH1—hematologic cancer	1.56e-05	0.000102	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK8—hematologic cancer	1.53e-05	0.0001	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CD80—hematologic cancer	1.53e-05	0.0001	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CD80—hematologic cancer	1.53e-05	0.0001	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CG—hematologic cancer	1.53e-05	0.0001	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KIT—hematologic cancer	1.53e-05	0.0001	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KIT—hematologic cancer	1.53e-05	0.0001	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CG—hematologic cancer	1.53e-05	0.0001	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTPN11—hematologic cancer	1.5e-05	9.84e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTPN11—hematologic cancer	1.5e-05	9.84e-05	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EP300—hematologic cancer	1.49e-05	9.78e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CREB1—hematologic cancer	1.45e-05	9.53e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CREB1—hematologic cancer	1.45e-05	9.53e-05	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SRC—hematologic cancer	1.45e-05	9.51e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1A—hematologic cancer	1.45e-05	9.49e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTEN—hematologic cancer	1.44e-05	9.47e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BRAF—hematologic cancer	1.44e-05	9.41e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BRAF—hematologic cancer	1.44e-05	9.41e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCL2—hematologic cancer	1.42e-05	9.32e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCL2—hematologic cancer	1.42e-05	9.32e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6R—hematologic cancer	1.42e-05	9.3e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6R—hematologic cancer	1.42e-05	9.3e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CREBBP—hematologic cancer	1.42e-05	9.28e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CREBBP—hematologic cancer	1.42e-05	9.28e-05	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—STAT3—hematologic cancer	1.4e-05	9.17e-05	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NRAS—hematologic cancer	1.4e-05	9.15e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EP300—hematologic cancer	1.38e-05	9.03e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAP2K1—hematologic cancer	1.35e-05	8.86e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAP2K1—hematologic cancer	1.35e-05	8.86e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CD—hematologic cancer	1.34e-05	8.8e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CD—hematologic cancer	1.34e-05	8.8e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SRC—hematologic cancer	1.34e-05	8.78e-05	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK3—hematologic cancer	1.34e-05	8.76e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—STAT3—hematologic cancer	1.29e-05	8.47e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NRAS—hematologic cancer	1.29e-05	8.45e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGF2—hematologic cancer	1.29e-05	8.43e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGF2—hematologic cancer	1.29e-05	8.43e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3R1—hematologic cancer	1.27e-05	8.31e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3R1—hematologic cancer	1.27e-05	8.31e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MAPK3—hematologic cancer	1.23e-05	8.09e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—JAK2—hematologic cancer	1.23e-05	8.08e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JAK2—hematologic cancer	1.23e-05	8.08e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MDM2—hematologic cancer	1.2e-05	7.88e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MDM2—hematologic cancer	1.2e-05	7.88e-05	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KRAS—hematologic cancer	1.2e-05	7.87e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—hematologic cancer	1.2e-05	7.87e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—hematologic cancer	1.2e-05	7.85e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MTOR—hematologic cancer	1.17e-05	7.67e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CB—hematologic cancer	1.17e-05	7.67e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CB—hematologic cancer	1.17e-05	7.67e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MTOR—hematologic cancer	1.17e-05	7.67e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KRAS—hematologic cancer	1.11e-05	7.27e-05	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CA—hematologic cancer	1.1e-05	7.23e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1B—hematologic cancer	1.1e-05	7.2e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1B—hematologic cancer	1.1e-05	7.2e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP3—hematologic cancer	1.08e-05	7.06e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP3—hematologic cancer	1.08e-05	7.06e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL2—hematologic cancer	1.08e-05	7.05e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL2—hematologic cancer	1.08e-05	7.05e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCND1—hematologic cancer	1.05e-05	6.87e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCND1—hematologic cancer	1.05e-05	6.87e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JUN—hematologic cancer	1.05e-05	6.85e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—JUN—hematologic cancer	1.05e-05	6.85e-05	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HRAS—hematologic cancer	1.02e-05	6.69e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CA—hematologic cancer	1.02e-05	6.68e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1A—hematologic cancer	1.01e-05	6.64e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1A—hematologic cancer	1.01e-05	6.64e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTEN—hematologic cancer	1.01e-05	6.63e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTEN—hematologic cancer	1.01e-05	6.63e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK8—hematologic cancer	9.9e-06	6.48e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK8—hematologic cancer	9.9e-06	6.48e-05	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—hematologic cancer	9.77e-06	6.41e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EP300—hematologic cancer	9.65e-06	6.32e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EP300—hematologic cancer	9.65e-06	6.32e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HRAS—hematologic cancer	9.43e-06	6.18e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SRC—hematologic cancer	9.38e-06	6.15e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SRC—hematologic cancer	9.38e-06	6.15e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—hematologic cancer	9.14e-06	5.99e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—hematologic cancer	9.14e-06	5.99e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT3—hematologic cancer	9.05e-06	5.93e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT3—hematologic cancer	9.05e-06	5.93e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NRAS—hematologic cancer	9.02e-06	5.91e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NRAS—hematologic cancer	9.02e-06	5.91e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—hematologic cancer	9.02e-06	5.91e-05	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT1—hematologic cancer	9.02e-06	5.91e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK3—hematologic cancer	8.64e-06	5.66e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK3—hematologic cancer	8.64e-06	5.66e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—hematologic cancer	8.41e-06	5.51e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—hematologic cancer	8.41e-06	5.51e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—hematologic cancer	8.39e-06	5.5e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—hematologic cancer	8.39e-06	5.5e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT1—hematologic cancer	8.32e-06	5.46e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KRAS—hematologic cancer	7.77e-06	5.09e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KRAS—hematologic cancer	7.77e-06	5.09e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CA—hematologic cancer	7.14e-06	4.68e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CA—hematologic cancer	7.14e-06	4.68e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—hematologic cancer	6.9e-06	4.52e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—hematologic cancer	6.9e-06	4.52e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HRAS—hematologic cancer	6.6e-06	4.33e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRAS—hematologic cancer	6.6e-06	4.33e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—hematologic cancer	6.32e-06	4.14e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—hematologic cancer	6.32e-06	4.14e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT1—hematologic cancer	5.83e-06	3.82e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT1—hematologic cancer	5.83e-06	3.82e-05	CbGpPWpGaD
